SECURITIES PURCHASE AGREEMENTSecurity Agreement • December 2nd, 2016 • Accelerated Pharma, Inc. • Pharmaceutical preparations • Delaware
· Collectively, the Company executed Securities Purchase Agreement Security Agreement, Notes, and Warrants are referred to as "Company Documents"; and
SECURITIES PURCHASE AGREEMENTSecurity Agreement • December 2nd, 2016 • Accelerated Pharma, Inc. • Pharmaceutical preparations • Delaware
· Collectively, the Company executed Securities Purchase Agreement Security Agreement, Notes, and Warrants are referred to as "Company Documents"; and
SEVENTH AMENDMENT, WAIVER AND CONSENTWaiver and Consent • December 2nd, 2016 • Accelerated Pharma, Inc. • Pharmaceutical preparations
This Seventh Amendment, Waiver and Consent (“Seventh Consent”), is made and entered into as of December 1, 2016, by and among Accelerated Pharma, Inc., a Delaware corporation (the “Company”), and the parties identified on the signature page hereto (each a “Purchaser” and collectively, “Purchasers”). Capitalized terms used but not defined herein will have the meanings assigned to them in the Securities Purchase Agreements and Transaction Documents (as defined below). Capitalized terms defined herein shall be incorporated in the Transaction Documents, as appropriate.
SECURITIES PURCHASE AGREEMENTExclusive License Agreement • December 2nd, 2016 • Accelerated Pharma, Inc. • Pharmaceutical preparations • New York
· Collectively, the Company executed Securities Purchase Agreement Security Agreement, Notes, and Warrants are referred to as "Company Documents"; and
AMENDED AND RESTATED FIFTH AMENDMENT, WAIVER AND CONSENTWaiver and Consent • December 2nd, 2016 • Accelerated Pharma, Inc. • Pharmaceutical preparations
This Amended and Restated Fifth Amendment, Waiver and Consent (“Amended Fifth Consent”) which supersedes the Fifth Amendment, Waiver and Consent entered into on July 15, 2016, is made and entered into as of September 20, 2016, by and among Accelerated Pharma, Inc., a Delaware corporation (the “Company”), and the parties identified on the signature page hereto (each a “Purchaser” and collectively, “Purchasers”). Capitalized terms used but not defined herein will have the meanings assigned to them in the Securities Purchase Agreements and Transaction Documents (as defined below). Capitalized terms defined herein shall be incorporated in the Transaction Documents, as appropriate.
AMENDMENT, WAIVER AND CONSENTWaiver and Consent • December 2nd, 2016 • Accelerated Pharma, Inc. • Pharmaceutical preparations
This Amendment, Waiver and Consent (“Consent”) is made and entered into as of May 8, 2015, by and among Accelerated Pharma, Inc., a Delaware corporation (the “Company”), and the parties identified on the signature page hereto (each a “Purchaser” and collectively, “Purchasers”). Capitalized terms used but not defined herein will have the meanings assigned to them in the Securities Purchase Agreements (as defined below).
SECURITIES PURCHASE AGREEMENTSecurity Agreement • December 2nd, 2016 • Accelerated Pharma, Inc. • Pharmaceutical preparations • New York
· Collectively, the Company executed Securities Purchase Agreement Security Agreement, Notes, and Warrants are referred to as "Company Documents"; and
FIFTH AMENDMENT, WAIVER AND CONSENTWaiver and Consent • December 2nd, 2016 • Accelerated Pharma, Inc. • Pharmaceutical preparations
This Fifth Amendment, Waiver and Consent (“Fifth Consent”) is made and entered into as of July 15 , 2016, by and among Accelerated Pharma, Inc., a Delaware corporation (the “Company”), and the parties identified on the signature page hereto (each a “Purchaser” and collectively, “Purchasers”). Capitalized terms used but not defined herein will have the meanings assigned to them in the Securities Purchase Agreements and Transaction Documents (as defined below). Capitalized terms defined herein shall be incorporated in the Transaction Documents, as appropriate.
THIRD AMENDMENT, WAIVER AND CONSENTWaiver and Consent • December 2nd, 2016 • Accelerated Pharma, Inc. • Pharmaceutical preparations
This Third Amendment, Waiver and Consent (“Third Consent”) is made and entered into as of March ___, 2016, by and among Accelerated Pharma, Inc., a Delaware corporation (the “Company”), and the parties identified on the signature page hereto (each a “Prior Purchaser” and collectively, “Prior Purchasers”). Capitalized terms used but not defined herein will have the meanings assigned to them in the Securities Purchase Agreements and Transaction Documents (as defined below). Capitalized terms defined herein shall be incorporated in the Transaction Documents, as appropriate.
SECOND AMENDMENT, WAIVER AND CONSENTWaiver and Consent • December 2nd, 2016 • Accelerated Pharma, Inc. • Pharmaceutical preparations
This Second Amendment, Waiver and Consent (“Second Consent”) is made and entered into as of October ___, 2015, by and among Accelerated Pharma, Inc., a Delaware corporation (the “Company”), and the parties identified on the signature page hereto (each a “Prior Purchaser” and collectively, “Prior Purchasers”). Capitalized terms used but not defined herein will have the meanings assigned to them in the Securities Purchase Agreements and Transaction Documents (as defined below). Capitalized terms defined herein shall be incorporated in the Transaction Documents, as appropriate.
FOURTH AMENDMENT, WAIVER AND CONSENTWaiver and Consent • December 2nd, 2016 • Accelerated Pharma, Inc. • Pharmaceutical preparations
This Fourth Amendment, Waiver and Consent (“Fourth Consent”) is made and entered into as of May ___, 2016, by and among Accelerated Pharma, Inc., a Delaware corporation (the “Company”), and the parties identified on the signature page hereto (each a “Purchaser” and collectively, “Purchasers”). Capitalized terms used but not defined herein will have the meanings assigned to them in the Securities Purchase Agreements and Transaction Documents (as defined below). Capitalized terms defined herein shall be incorporated in the Transaction Documents, as appropriate.
